SlideShare a Scribd company logo
 
Effect of the Ideal Protein Weight
Loss Method on Weight Loss
and Metabolic Parameters
By: Timothy Logemann, MD; David K. Murdock, MD, MS; Kelly O’Heron, RD & Adam Hoffmann
HVR-037b
ABSTRACT
Background:
Obesity is a national health crisis. The Ideal Protein Weight Loss Method (IPWLM) is a 4 stage,
low carbohydrate, ketogenic diet that promotes weight loss. Stage 1 of IPWLM is a partial meal
replacement, low carbohydrate, low fat, normal protein diet of about 1,200 calories and 40
grams of carbohydrate daily, resulting in ketosis. This stage is continued until target weight is
achieved. We sought to quantify the 12-week results of this program in a large population in
terms of weight loss, and also its effect on metabolic parameters.
Methods:
272 patients enrolled in the IPWLM. Weekly meetings were encouraged with a health coach to
review progress and compliance. Patients consume 3-5 Ideal Protein products per day based
on their weight, vitamin and mineral supplements, 4 cups low carbohydrate vegetables, 8 oz
of lean protein and lettuce. The patients’ had weight, waist size, body mass index (BMI), blood
pressure (BP), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein
(LDL), triglyceride, and glucose levels collected prior to starting the IPWLM and after 12
weeks on the diet. A statistical paired t-test was performed on all measurements.
Results:
233 patients completed the 12 weeks which is a compliancy rate of 85.7%. The results show
a decrease in all categories except HDL. Males averaged a loss of 3.5 pounds per week (PPW)
and females 2.5 PPW. Average weight went from 228.4±47.8 to 195.0±41.8 lbs. Average
waist size decreased from 45.2±6.2 to 39.9±5.9 inches and BMI dropped from 36.5±6.3 to
31.1±5.7.ThesystolicBPdecreasedfrom126.2±15.9to115.4±13.8mmHganddiastolicwas
reduced from 80.0±9.4 to 73.3±9.7 mmHg. TC decreased 184.0±38.8 to 158.2±35.8 mg/
dl, LDL from 106.2±33.9 to 91.6±29.9 mg/dl, triglycerides from 129.9±73.5 to 71.3±38.6
mg/dl, and glucose from 110.8±35.8 to 96.3±12.5 mg/dl (p<0.001 for all changes). HDL
levels had no significant change (p<0.779).
Conclusion:
The IPWLM results in rapid weight loss and marked improvement in metabolic parameters in
a short period of time. Further investigation of the IPWLM on individual and population health
and long term results is indicated.
Final Conclusions:
1) The IPWLM produces significant weight loss over a 12-
week period with a high compliance rate.
2) Significantimprovementsinbloodpressure,lipidprofile,
and fasting glucose levels suggest the method should
decrease cardiovascular risk.
3) Further research is required to determine the long term
complianceandtheeffectoncardiovascularriskfactors.
Methods:
1) 272 patients were enrolled into the IPWLM which
included:
review compliance and progress
per day based on weight
2) Measurements were collected at the beginning of the
program and at 12 weeks and included:
Pressure (BP), Total Cholesterol (TC), High-density
lipoprotein (HDL), Low-density lipoprotein (LDL),
Triglyceride, Glucose
3) Pre and post measurements were compared with all
patients using the T-Test.
Results:
1) 233 patients completed at least 12 weeks of the diet
with 86% compliance.
2) Average weekly weight loss was about 3.5 lbs for males
and 2.5 lbs for females.
3) Meanweightdecreasedfrom228.4±47.8 to 195.0±41.8
lbs (p<0.001).
4) Waist size average decreased from 45.2±6.2 to
39.9±5.9 inches (p<0.001).
5) BMI decreased from 36.5±6.3 to 31.1±5.7 (p<0.001).
6) The systolic BP decreased from 126.2±15.9 to
115.4±13.8 mmHg and diastolic was reduced from
80.0±9.4 to 73.3±9.7 mmHg (p<0.001).
Introduction:
is a 4-stage ketogenic diet with low carbohydrate, low
fat and normal protein.
of carbohydrates daily.
in a large population in terms of weight loss and its
effect on metabolic parameters.
(p<0.001)
(p<0.001)
(p<0.001)
(p<0.001)
(p<0.001)

More Related Content

PPTX
Gme journal6
PDF
Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...
PPT
Protein and glycemic index in weight maintenance larsen 2010
PPT
Dr. Ali java
PPT
Clinical Research Methodology in Obesity
PPTX
Semaglutide journal club
PDF
IAND assembly HD omega 3 poster
PDF
SARCOPENIC OBESITY – A CLINICAL REVIEW
Gme journal6
Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...
Protein and glycemic index in weight maintenance larsen 2010
Dr. Ali java
Clinical Research Methodology in Obesity
Semaglutide journal club
IAND assembly HD omega 3 poster
SARCOPENIC OBESITY – A CLINICAL REVIEW

What's hot (19)

PPT
Surgical Options for Weight Loss
PDF
Case study on Holistic Diabetic Care using Diet, Yoga, Resisted Exercises usi...
PDF
direct-protocol
PDF
Treatment of obesity (and diabetes)
PDF
Queen's Study
PPT
The Management Of Obesity
PDF
Welch Final Poster
PPTX
Effect of fruit restriction on glycemic control in patients with type 2 diabe...
PDF
Fat as a Health Food: Benefits & Course Corrections During a Year of Tracking...
PPTX
Pharmacotherpy & Recent Advances in Obesity Management
PPT
Metabolic surgery
PDF
Is Fat Healthy for Me? Benefits & Course Corrections During a Year of Ketosi...
PPT
Israt ara hossain nst 17-18
PDF
Effectiveness of Continuous Remote Care and Nutritional Ketosis for Type 2 Di...
PPTX
Surgical Management Of Obesity & Its Complications
PPTX
SCOPE School Dublin - Deborah Horn
PPT
Weightma2
PPT
SCOPE School Dublin - Carel Le Roux
Surgical Options for Weight Loss
Case study on Holistic Diabetic Care using Diet, Yoga, Resisted Exercises usi...
direct-protocol
Treatment of obesity (and diabetes)
Queen's Study
The Management Of Obesity
Welch Final Poster
Effect of fruit restriction on glycemic control in patients with type 2 diabe...
Fat as a Health Food: Benefits & Course Corrections During a Year of Tracking...
Pharmacotherpy & Recent Advances in Obesity Management
Metabolic surgery
Is Fat Healthy for Me? Benefits & Course Corrections During a Year of Ketosi...
Israt ara hossain nst 17-18
Effectiveness of Continuous Remote Care and Nutritional Ketosis for Type 2 Di...
Surgical Management Of Obesity & Its Complications
SCOPE School Dublin - Deborah Horn
Weightma2
SCOPE School Dublin - Carel Le Roux
Ad

Similar to ASPIRUS metabolic parameters#1 (20)

PPTX
Drug for Treating Obesity
PPTX
DIABETES REMISSION MYTHS AND FACTS !!!!!
PPT
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
PPT
Obesity. diet, exercise and drugs june 2012
PPTX
American Gastroenterology association obesity management latest guidelines
PPTX
Intermittent Fasting and Diabesity a new hope.pptx
PDF
Continuous Care Intervention in Type 2 Diabetes
PPTX
Non alcoholic fatty liver disease: what can we do about it?
PDF
Consumption of Synbiotic Bread Decreases Triacylglycerol and VLDL Levels Whil...
DOC
Group activity-module-2
PPTX
Slides Lezing Dr. Ir. Ben van Ommen TNO leefstijlcongres
PPTX
Ramadan and Insulin use for diabetic patients
PPTX
HXR 2016: Which Comes First: Overeating or Obesity? -Dr. David Ludwig, Boston...
PPTX
Diabetes Reversal - MYTHS VS FACTS !!!!!!
PPTX
Metabolic surgery
PPTX
Obesity dr njeru
PDF
Ueda2015 lilly.the art of insulin dr.mesbah sayed
PPTX
mss_2022_11_03_kanaley_21-00425_sdc1.pptx
PPTX
Recent Advances in Obesity Pharmacotherapy
PPTX
obesity - a systematic approach
Drug for Treating Obesity
DIABETES REMISSION MYTHS AND FACTS !!!!!
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
Obesity. diet, exercise and drugs june 2012
American Gastroenterology association obesity management latest guidelines
Intermittent Fasting and Diabesity a new hope.pptx
Continuous Care Intervention in Type 2 Diabetes
Non alcoholic fatty liver disease: what can we do about it?
Consumption of Synbiotic Bread Decreases Triacylglycerol and VLDL Levels Whil...
Group activity-module-2
Slides Lezing Dr. Ir. Ben van Ommen TNO leefstijlcongres
Ramadan and Insulin use for diabetic patients
HXR 2016: Which Comes First: Overeating or Obesity? -Dr. David Ludwig, Boston...
Diabetes Reversal - MYTHS VS FACTS !!!!!!
Metabolic surgery
Obesity dr njeru
Ueda2015 lilly.the art of insulin dr.mesbah sayed
mss_2022_11_03_kanaley_21-00425_sdc1.pptx
Recent Advances in Obesity Pharmacotherapy
obesity - a systematic approach
Ad

ASPIRUS metabolic parameters#1

  • 1.   Effect of the Ideal Protein Weight Loss Method on Weight Loss and Metabolic Parameters By: Timothy Logemann, MD; David K. Murdock, MD, MS; Kelly O’Heron, RD & Adam Hoffmann HVR-037b ABSTRACT Background: Obesity is a national health crisis. The Ideal Protein Weight Loss Method (IPWLM) is a 4 stage, low carbohydrate, ketogenic diet that promotes weight loss. Stage 1 of IPWLM is a partial meal replacement, low carbohydrate, low fat, normal protein diet of about 1,200 calories and 40 grams of carbohydrate daily, resulting in ketosis. This stage is continued until target weight is achieved. We sought to quantify the 12-week results of this program in a large population in terms of weight loss, and also its effect on metabolic parameters. Methods: 272 patients enrolled in the IPWLM. Weekly meetings were encouraged with a health coach to review progress and compliance. Patients consume 3-5 Ideal Protein products per day based on their weight, vitamin and mineral supplements, 4 cups low carbohydrate vegetables, 8 oz of lean protein and lettuce. The patients’ had weight, waist size, body mass index (BMI), blood pressure (BP), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride, and glucose levels collected prior to starting the IPWLM and after 12 weeks on the diet. A statistical paired t-test was performed on all measurements. Results: 233 patients completed the 12 weeks which is a compliancy rate of 85.7%. The results show a decrease in all categories except HDL. Males averaged a loss of 3.5 pounds per week (PPW) and females 2.5 PPW. Average weight went from 228.4±47.8 to 195.0±41.8 lbs. Average waist size decreased from 45.2±6.2 to 39.9±5.9 inches and BMI dropped from 36.5±6.3 to 31.1±5.7.ThesystolicBPdecreasedfrom126.2±15.9to115.4±13.8mmHganddiastolicwas reduced from 80.0±9.4 to 73.3±9.7 mmHg. TC decreased 184.0±38.8 to 158.2±35.8 mg/ dl, LDL from 106.2±33.9 to 91.6±29.9 mg/dl, triglycerides from 129.9±73.5 to 71.3±38.6 mg/dl, and glucose from 110.8±35.8 to 96.3±12.5 mg/dl (p<0.001 for all changes). HDL levels had no significant change (p<0.779). Conclusion: The IPWLM results in rapid weight loss and marked improvement in metabolic parameters in a short period of time. Further investigation of the IPWLM on individual and population health and long term results is indicated. Final Conclusions: 1) The IPWLM produces significant weight loss over a 12- week period with a high compliance rate. 2) Significantimprovementsinbloodpressure,lipidprofile, and fasting glucose levels suggest the method should decrease cardiovascular risk. 3) Further research is required to determine the long term complianceandtheeffectoncardiovascularriskfactors. Methods: 1) 272 patients were enrolled into the IPWLM which included: review compliance and progress per day based on weight 2) Measurements were collected at the beginning of the program and at 12 weeks and included: Pressure (BP), Total Cholesterol (TC), High-density lipoprotein (HDL), Low-density lipoprotein (LDL), Triglyceride, Glucose 3) Pre and post measurements were compared with all patients using the T-Test. Results: 1) 233 patients completed at least 12 weeks of the diet with 86% compliance. 2) Average weekly weight loss was about 3.5 lbs for males and 2.5 lbs for females. 3) Meanweightdecreasedfrom228.4±47.8 to 195.0±41.8 lbs (p<0.001). 4) Waist size average decreased from 45.2±6.2 to 39.9±5.9 inches (p<0.001). 5) BMI decreased from 36.5±6.3 to 31.1±5.7 (p<0.001). 6) The systolic BP decreased from 126.2±15.9 to 115.4±13.8 mmHg and diastolic was reduced from 80.0±9.4 to 73.3±9.7 mmHg (p<0.001). Introduction: is a 4-stage ketogenic diet with low carbohydrate, low fat and normal protein. of carbohydrates daily. in a large population in terms of weight loss and its effect on metabolic parameters. (p<0.001) (p<0.001) (p<0.001) (p<0.001) (p<0.001)